Nerve Agent Treatment Program

About DynPort Vaccines

DynPort Vaccine Company (DVC) is a U.S.-based government services contractor specializing in the development and licensure of vaccines and therapeutics for biodefense and public health emergencies. Operating as part of GDIT, it provides end-to-end program management, regulatory strategy, clinical research, and manufacturing oversight for complex government-funded medical countermeasure programs. With over two decades of experience, DVC has a proven track record in navigating the FDA regulatory pathway, including submissions under the Animal Rule, and serves as a critical partner for federal agencies in protecting military and civilian populations.

Therapeutic Areas